Insider Transactions in Q2 2017 at Bristol Myers Squibb CO (BMY)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
May 14 2017	Thomas J. Lynch Jr. EVP & Chief Scientific Officer	BUY Exercise of conversion of derivative security	Direct	14,550 +50.0%	-
May 05 2017	Giovanni Caforio Executive Chair of the Board	SELL Payment of exercise price or tax liability	Direct	3,446 -1.92%	$189,530 $55.15 P/Share
May 05 2017	Giovanni Caforio Executive Chair of the Board	SELL Other acquisition or disposition	Direct	1,384 -0.77%	-
May 05 2017	Giovanni Caforio Executive Chair of the Board	BUY Exercise of conversion of derivative security	Direct	8,040 +4.27%	-
Apr 07 2017	Lamberto Andreotti Director	SELL Open market or private sale	Direct	17,000 -1.78%	$901,000 $53.22 P/Share
Apr 06 2017	Lamberto Andreotti Director	SELL Open market or private sale	Direct	17,000 -1.75%	$901,000 $53.29 P/Share
Apr 01 2017	Ann Powell EVP, Chief Human Resources	SELL Payment of exercise price or tax liability	Direct	700 -1.59%	$37,800 $54.38 P/Share
Apr 01 2017	Ann Powell EVP, Chief Human Resources	BUY Exercise of conversion of derivative security	Direct	1,554 +3.4%	-

Receive a notification when an Institution or Guru buys or sells BMY shares.

Notify only if

Value

Get notified when an Bristol Myers Squibb CO insider buys or sells BMY shares.

Notify only if

Operation

Value

Type

Receive news related to BRISTOL MYERS SQUIBB CO